{"id":"9c75b380-8657-4f59-ba05-55e438eea7a9","name":"Abbott","slug":"abbott","description":"Abbott Laboratories is an American healthcare company based in Abbott Park, Illinois, developing continuous glucose monitoring systems (FreeStyle Libre, Lingo) with biometric sensors and wearable health monitoring technology for diabetes management.","status":"public (NYSE: ABT)","founded":1888,"hq":"Abbott Park, IL","fundingTotal":null,"type":"both","reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://abbott.mediaroom.com/2024-06-10-Abbott-Receives-FDA-Clearance-for-Two-Over-the-Counter-Continuous-Glucose-Monitoring-Systems","title":"Abbott receives FDA clearance for two OTC CGM systems (Lingo + Libre Rio; FDA 510(k) K233655 decided May 29 2024; adults 18+ not on insulin)","sourceName":"Abbott (newsroom)"},{"url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K233655","title":"FDA 510(k) K233655: OTC integrated continuous glucose monitoring system (Class II, 21 CFR 862.1355; adults 18+ not on insulin; not for diagnosis of any disease)","sourceName":"FDA 510(k) database"},{"url":"https://www.hellolingo.com/","title":"Lingo biosensor + app (Lingo Count adaptive metric, personalized recommendations, Lingo Challenges; 14-day biosensor; entry $54 / 2-week plan; Lingo Live = human nutritionist sessions)","sourceName":"Abbott / Lingo (official)"}],"keyFacts":[{"label":"Product","value":"Lingo OTC glucose biosensor (FDA 510(k) K233655, May 2024) + adaptive insight app (Lingo Count); built on FreeStyle Libre."},{"label":"Boundary","value":"Glucose-biometric + adaptive insight -> narrow INCLUDE; AI is adaptive/algorithmic, NOT generative (not at Stelo parity)."},{"label":"Ticker","value":"NYSE: ABT"},{"label":"Business unit","value":"Abbott Diabetes Care"},{"label":"Target population","value":"Non-diabetic / wellness consumers, adults 18+ not on insulin"}],"aliases":["Abbott Laboratories","Abbott Diabetes Care","Lingo"],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"createdAt":"2026-06-03T23:33:06.188Z","updatedAt":"2026-07-07T21:15:55.666Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/abbott","url":"https://registry.deploy.report/companies/abbott","name":"Abbott","alternateName":["Abbott Laboratories","Abbott Diabetes Care","Lingo"],"description":"Abbott Laboratories is an American healthcare company based in Abbott Park, Illinois, developing continuous glucose monitoring systems (FreeStyle Libre, Lingo) with biometric sensors and wearable health monitoring technology for diabetes management.","identifier":"9c75b380-8657-4f59-ba05-55e438eea7a9","foundingDate":"1888","address":"Abbott Park, IL","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":3,"primary_source_types":["primary-company-ir","primary-fda-database"]}}}